Thyroid status does not change your genetic predisposition to GLP-1 response
However, in rare cases, kidney injury has been reported, and the Food and Drug Administration (FDA) has not approved Ozempic for chronic kidney disease (CKD) treatment
In the Standards of Medical Care in Diabetes2021, the ADA recommend that for people with indications of high risk or established CKD either a sodium-glucose co-transporter-2 inhibitor (SGLT2i) or a glucagon-like peptide-1 receptor agonist (GLP-1 RA) be considered as a treatment option, independently of metformin use [15]
But these statistics are the results of observational studies
At Klinic, we simplify semaglutide insurance coverage in Huntington Beach by verifying your plan, checking coverage for brands like Wegovy, and managing the prior authorization process entirely, so you don't have to